Meiji Yasuda Asset Management CO Ltd. Catalent, Inc. Transaction History

Meiji Yasuda Asset Management CO Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 16, 2022	BUY	$87.2 - $114.05 $173,528 - $226,959	1,990 New	1,990 $214,000
Q1 2022 May 17, 2022	SELL	$94.19 - $124.49 $188,380 - $248,980	-2,000 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$119.57 - $139.07 $29,892 - $34,767	250 Added 14.29%	2,000 $256,000
Q3 2021 Nov 12, 2021	BUY	$109.17 - $142.35 $191,047 - $249,112	1,750 New	1,750 $233,000

513

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Meiji Yasuda Asset Management CO Ltd., based on Form 13F filings with the SEC.

Stay updated on Meiji Yasuda Asset Management CO Ltd. with notifications on news.